Clinical trials
Phase 3 trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6,786 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 34 |
| 2001 | 76 |
| 2002 | 92 |
| 2003 | 146 |
| 2004 | 222 |
| 2005 | 223 |
| 2006 | 289 |
| 2007 | 262 |
| 2008 | 320 |
| 2009 | 299 |
| 2010 | 305 |
| 2011 | 315 |
| 2012 | 276 |
| 2013 | 273 |
| 2014 | 284 |
| 2015 | 302 |
| 2016 | 261 |
| 2017 | 272 |
| 2018 | 313 |
| 2019 | 268 |
| 2020 | 265 |
| 2021 | 317 |
| 2022 | 263 |
| 2023 | 268 |
| 2024 | 274 |
| 2025 | 286 |
| 2026 | 173 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4,444 |
| Terminated | 771 |
| Active, not recruiting | 722 |
| Recruiting | 578 |
| Unknown status | 172 |
| Withdrawn | 39 |
| Enrolling by invitation | 30 |
| Not yet recruiting | 26 |
| Suspended | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 381 |
| AstraZeneca | 306 |
| Hoffmann-La Roche | 286 |
| GlaxoSmithKline | 252 |
| Eli Lilly and Company | 220 |
| Pfizer | 191 |
| Sanofi | 181 |
| Boehringer Ingelheim | 171 |
| Bristol-Myers Squibb | 142 |
| Novo Nordisk A/S | 131 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 275 |
| Breast Neoplasms | 207 |
| Carcinoma, Non-Small-Cell Lung | 202 |
| Pulmonary Disease, Chronic Obstructive | 142 |
| Neoplasms | 138 |
| Diabetes Mellitus | 131 |
| Hypertension | 119 |
| Arthritis, Rheumatoid | 112 |
| Asthma | 111 |
| Multiple Myeloma | 107 |
Trials
Showing 1 to 25 of 6,786. Each trial links to its page on Pharma Observatory.
6,686 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.